Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast in Asthma
NCT00073177Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of roflumilast in asthma, sponsored by AstraZeneca. Started Nov 2003; status: completed.
02
Drugs
roflumilast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00073177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073177.